spiperone has been researched along with Cranial Nerve V Diseases in 1 studies
Spiperone: A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.
spiperone : An azaspiro compound that is 1,3,8-triazaspiro[4.5]decane which is substituted at positions 1, 4, and 8 by phenyl, oxo, and 4-(p-fluorophenyl)-4-oxobutyl groups, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, S | 1 |
| Tang, Y | 1 |
| Shu, H | 1 |
| Tatum, D | 1 |
| Bai, Q | 1 |
| Crawford, J | 1 |
| Xing, Y | 1 |
| Lobo, MK | 1 |
| Bellinger, L | 1 |
| Kramer, P | 1 |
| Tao, F | 1 |
1 other study available for spiperone and Cranial Nerve V Diseases
| Article | Year |
|---|---|
Dopamine receptor D2, but not D1, mediates descending dopaminergic pathway-produced analgesic effect in a trigeminal neuropathic pain mouse model.
Topics: Animals; Benzazepines; Brain; CCAAT-Enhancer-Binding Protein-beta; Channelrhodopsins; Conditioning, | 2019 |